Sequenom, Inc. (NASDAQ:SQNM) Notifies IMPACT DX System And Others

Boston, MA 10/18/2013 (wallstreetpr) – Sequenom, Inc. (NASDAQ:SQNM) an innovator in the clinical research and clinical molecular diagnostic instrumentation, technology and tests has notified two of its latest products: “IMPACT Dx™ System and its IMPACT Dx™ Factor V Leiden and Factor II Genotyping Test” with FDA, in early October. Both the system and the test are […]